Mr. Dourado brings over 16 years of experience in biotechnology business development and joined in May 2016 Poseida from Ligand Pharmaceuticals, where he led business development efforts as senior director, business development. Mr. Dourado previously worked at Sanford Burnham Medical Research Institute, Metabasis Therapeutics, The Dow Chemical Company, Agouron Pharmaceuticals and Johnson & Johnson. Mr. Dourado holds an MBA from Queen’s University, a M.S. from the University of Calgary and a B.S. from the University of Alberta.